CoChat

A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles

Open access

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Abstract

Our aim was to determine the quantitative effects of a single-dose of Nattokinase (NK) administration on coagulation/fibrinolysis parameters comprehensively in healthy male subjects. A double-blind, placebo-controlled cross-over NK intervention study was carried out in 12 healthy young males. Following the baseline blood draw, each subject was randomized to receive either a single-dose of 2,000 FU NK (NSK-SD, Japan Bio Science Laboratory Co., Ltd) or placebo with subsequent cross-over of the groups. Subjects donated blood samples at 2, 4, 6 and 8 hours following administration for analysis of coagulation/fibrinolysis parameters. As a result, D-dimer concentrations at 6 and 8 hours and blood fibrin/fibrinogen degradation products at 4 hours after NK administration elevated significantly (p < 0.05, respectively). Factor VIII activity declined at 4 and 6 hours (p < 0.05, respectively), blood antithrombin concentration was higher at 2 and 4 hours (p < 0.05, respectively) and the activated partial thromboplastin time prolonged significantly at 2 and 4 hours following NK administration (p < 0.05 and p < 0.01, respectively). All the changes, however, were within the normal range. In conclusion, thus, a single-dose of NK administration appears enhancing fibrinolysis and anti-coagulation via several different pathways simultaneously.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep11601

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 This figure shows the study design and the experimental procedures.
Figure 1 This figure shows the study design and the experimental procedures.CC BY · PubMed Central
Figure 2 The figures show the fibrinolysis/coagulation parameters before and after a 2,000 FU of NK administration or placebo in twelve healthy young male, double blind crossover placebo-controlled design. Data are expressed as mean ± SEM. Statistically significant when compared with placebo: *P < 0.05, **P < 0.01.
Figure 2 The figures show the fibrinolysis/coagulation parameters before and after a 2,000 FU of NK administration or placebo in twelve healthy young male, double blind crossover placebo-controlled design. Data are expressed as mean ± SEM. Statistically significant when compared with placebo: *P < 0.05, **P < 0.01.CC BY · PubMed Central
Figure 3 This figure shows the diagram of blood coagulation/fibrinolysis cascade. White colored factors with black background were altered by a single-dose of NK administration.
Figure 3 This figure shows the diagram of blood coagulation/fibrinolysis cascade. White colored factors with black background were altered by a single-dose of NK administration.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. Fukuda, S., Matsui, T., Tachibana, H., Tomoda, T. & Ohsugi, M. Development of functional soybean foods produced by fermentation with mushroom mycelia. Bull Mukogawa Women’s Univ Nat Sci. 55, 53–59 (2007).

Cited by

See all 115

Metadata

Authors
Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J. F., & Hamaoka, T.
Affiliations
  • Ritsumeikan University (JP)
  • Shunan University (JP)
  • Kobe Pharmaceutical University (JP)
  • University of Cincinnati (US)
Corresponding author
Hamaoka, Takafumi
Venue
Scientific Reports
Published
2015-06-25
Volume
5
Issue
1
Pages
11601-11601
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2404423380
Cited by
115
References
21
Citations by year
2026: 6 · 2025: 13 · 2024: 18 · 2023: 16 · 2022: 12 · 2021: 16 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 8 · 2016: 3
FWCI
4.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • University of Cincinnati
  • Japan Society for the Promotion of Science (26350824)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Hematology › Blood properties and coagulation
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords
nattokinase, fibrinolysis, coagulation, thrombolysis, anticoagulation, D-dimer, fibrin/fibrinogen degradation products, factor VIII, antithrombin III, activated partial thromboplastin time, single-dose administration, healthy men
MeSH terms
Antithrombins, Blood Coagulation, Blood Coagulation Tests, Double-Blind Method, Factor VIII, Fibrin, Fibrin Fibrinogen Degradation Products, Fibrinogen, Fibrinolysis, Fibrinolytic Agents, Humans, Male, Partial Thromboplastin Time, Subtilisins, Time Factors, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.